Literature DB >> 28962153

Turner syndrome caused by rare complex structural abnormalities involving chromosome X.

Niu Li1,2, Li Zhao3, Juan Li3, Yu Ding3, Yongnian Shen3, Xiaodong Huang3, Xiumin Wang1,3, Jian Wang1,2.   

Abstract

Turner syndrome (TS) is a phenotypic heterogeneous genetic disorder caused by the loss of an X-chromosome or X-structural abnormalities in the X-chromosome, and affects approximately 1 in every 2,500 females. The affected individuals may develop diverse clinical features, including short stature, ovarian dysgenesis, skeletal dysplasia, facial abnormalities and other disorders. A constitutional karyotype of 45, X accounts for nearly 50% of TS patients, while X-mosaicism and other X-chromosomal structural abnormalities, including deletions, duplications, ring, isodicentric chromosomes, inversions and translocations, have been reported in other cases. The present study reports the results of chromosome microarray analysis (CMA) in two Chinese female TS patients with idiosyncratic karyotypes. The first patient had a karyotype of 46, X, der(X), and the CMA results demonstrated that the derivative chromosome was an abnormal X-chromosome that consisted of three deletions (Xp21.3-p11.23, Xp11.1-q13.1 and Xq21.31-q28), as well as three duplications (Xp22.33-p21.3, Xp11.23-p11.1 and Xq13.1-q21.31). The karyotype of the second patient was 46, X, der(X) t(X;?)(q 22.1;?),inv(11)(q13.5q21), while CMA revealed an Xq21.2-q27.1 duplication and an Xq27.2-q28 deletion. In conclusion, the current study performed genotype-phenotype correlation analysis in two patients and provided novel insight of the genotype of TS.

Entities:  

Keywords:  Turner syndrome; X-chromosomal structural abnormalities; short stature; short stature homeobox gene

Year:  2017        PMID: 28962153      PMCID: PMC5609171          DOI: 10.3892/etm.2017.4756

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

Review 1.  Recommendations for the diagnosis and management of Turner syndrome.

Authors:  P Saenger; K A Wikland; G S Conway; M Davenport; C H Gravholt; R Hintz; O Hovatta; M Hultcrantz; K Landin-Wilhelmsen; A Lin; B Lippe; A M Pasquino; M B Ranke; R Rosenfeld; M Silberbach
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

Review 2.  Turner's syndrome.

Authors:  Virginia P Sybert; Elizabeth McCauley
Journal:  N Engl J Med       Date:  2004-09-16       Impact factor: 91.245

3.  Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group.

Authors:  Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2006-10-17       Impact factor: 5.958

Review 4.  Turner's syndrome.

Authors:  M B Ranke; P Saenger
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

Review 5.  Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.

Authors:  K A Leppig; C M Disteche
Journal:  Semin Reprod Med       Date:  2001-06       Impact factor: 1.303

6.  Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location.

Authors:  C A Boucher; C A Sargent; T Ogata; N A Affara
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

Review 7.  Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features.

Authors:  T Ogata; N Matsuo
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

8.  Laboratory guideline for Turner syndrome.

Authors:  Daynna J Wolff; Daniel L Van Dyke; Cynthia M Powell
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

9.  Turner syndrome presented with tall stature due to overdosage of the SHOX gene.

Authors:  Go Hun Seo; Eungu Kang; Ja Hyang Cho; Beom Hee Lee; Jin-Ho Choi; Gu-Hwan Kim; Eul-Ju Seo; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

10.  Chromosome X-wide association study identifies Loci for fasting insulin and height and evidence for incomplete dosage compensation.

Authors:  Taru Tukiainen; Matti Pirinen; Antti-Pekka Sarin; Claes Ladenvall; Johannes Kettunen; Terho Lehtimäki; Marja-Liisa Lokki; Markus Perola; Juha Sinisalo; Efthymia Vlachopoulou; Johan G Eriksson; Leif Groop; Antti Jula; Marjo-Riitta Järvelin; Olli T Raitakari; Veikko Salomaa; Samuli Ripatti
Journal:  PLoS Genet       Date:  2014-02-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.